NCT02658565View on ClinicalTrials.gov

Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation

NAActive, not recruitingINTERVENTIONAL

Enrollment

401

Participants

Timeline

Start Date

January 29, 2016

Primary Completion Date

December 8, 2023

Study Completion Date

November 30, 2026

Conditions

Endometrial Cancer

Interventions

PROCEDURE

Lymphadenectomy

Lymphadenectomy recommended, including: obturator, iliac (internal, external, common) and aortic lymph nodes

Trial Locations (1)

40506

University of Kentucky, Lexington

All Listed Sponsors

lead

Frederick R. Ueland, M.D.

OTHER

NCT02658565 - Selective Surgical Staging for the Treatment of Endometrial Cancer Based on Intraoperative Consultation | Biotech Hunter | Biotech Hunter